| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.26e-07 | 28 | 105 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1G ATP7A ACSF2 OLA1 DHX30 DNAH1 CCT5 NAV3 MACF1 ASCC3 DNAH5 DNAH8 SNRNP200 | 2.02e-05 | 614 | 105 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 3.02e-05 | 231 | 105 | 8 | GO:0005085 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.09e-04 | 18 | 105 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.11e-04 | 441 | 105 | 10 | GO:0016887 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | NUDT14 ATP7A OLA1 NUDT17 DHX30 PRUNE1 CCT5 NAV3 MACF1 ASCC3 DNAH5 DNAH8 SNRNP200 | 4.56e-04 | 839 | 105 | 13 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | NUDT14 ATP7A OLA1 NUDT17 DHX30 PRUNE1 CCT5 NAV3 MACF1 ASCC3 DNAH5 DNAH8 SNRNP200 | 4.61e-04 | 840 | 105 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | NUDT14 ATP7A OLA1 NUDT17 DHX30 PRUNE1 CCT5 NAV3 MACF1 ASCC3 DNAH5 DNAH8 SNRNP200 | 4.61e-04 | 840 | 105 | 13 | GO:0016818 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 9.64e-04 | 37 | 105 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 1.42e-03 | 507 | 105 | 9 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 1.42e-03 | 507 | 105 | 9 | GO:0030695 | |
| GeneOntologyMolecularFunction | small GTPase binding | 1.54e-03 | 321 | 105 | 7 | GO:0031267 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 1.30e-05 | 210 | 106 | 8 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 1.54e-05 | 215 | 106 | 8 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 1.54e-05 | 215 | 106 | 8 | GO:0001539 | |
| GeneOntologyBiologicalProcess | cilium movement | 6.11e-05 | 261 | 106 | 8 | GO:0003341 | |
| GeneOntologyCellularComponent | USH2 complex | 1.52e-04 | 4 | 106 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.69e-04 | 25 | 106 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 3.77e-04 | 6 | 106 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 3.77e-04 | 6 | 106 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 6.99e-04 | 8 | 106 | 2 | GO:0002139 | |
| Domain | CCM2_C | 3.07e-05 | 2 | 104 | 2 | IPR032375 | |
| Domain | CCM2_C | 3.07e-05 | 2 | 104 | 2 | PF16545 | |
| Domain | Malcavernin | 3.07e-05 | 2 | 104 | 2 | IPR026159 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.84e-05 | 14 | 104 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.84e-05 | 14 | 104 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.84e-05 | 14 | 104 | 3 | IPR013602 | |
| Domain | DHC_N2 | 5.84e-05 | 14 | 104 | 3 | PF08393 | |
| Domain | MT | 5.84e-05 | 14 | 104 | 3 | PF12777 | |
| Domain | AAA_8 | 5.84e-05 | 14 | 104 | 3 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 5.84e-05 | 14 | 104 | 3 | IPR011704 | |
| Domain | AAA_5 | 5.84e-05 | 14 | 104 | 3 | PF07728 | |
| Domain | GDS_CDC24_CS | 6.42e-05 | 39 | 104 | 4 | IPR001331 | |
| Domain | DHC_fam | 7.27e-05 | 15 | 104 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 7.27e-05 | 15 | 104 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 7.27e-05 | 15 | 104 | 3 | PF03028 | |
| Domain | Sec63 | 1.83e-04 | 4 | 104 | 2 | PF02889 | |
| Domain | Sec63 | 1.83e-04 | 4 | 104 | 2 | SM00973 | |
| Domain | Sec63-dom | 1.83e-04 | 4 | 104 | 2 | IPR004179 | |
| Domain | BAAT_C | 3.04e-04 | 5 | 104 | 2 | IPR014940 | |
| Domain | BAAT_C | 3.04e-04 | 5 | 104 | 2 | PF08840 | |
| Domain | DH_1 | 4.20e-04 | 63 | 104 | 4 | PS00741 | |
| Domain | RhoGEF | 5.62e-04 | 68 | 104 | 4 | SM00325 | |
| Domain | ARM-type_fold | 6.16e-04 | 339 | 104 | 8 | IPR016024 | |
| Domain | RhoGEF | 6.27e-04 | 70 | 104 | 4 | PF00621 | |
| Domain | DH_2 | 6.27e-04 | 70 | 104 | 4 | PS50010 | |
| Domain | DH-domain | 6.62e-04 | 71 | 104 | 4 | IPR000219 | |
| Domain | - | 6.62e-04 | 71 | 104 | 4 | 1.20.900.10 | |
| Domain | ARM-like | 7.87e-04 | 270 | 104 | 7 | IPR011989 | |
| Domain | DHC_N1 | 8.41e-04 | 8 | 104 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 8.41e-04 | 8 | 104 | 2 | IPR013594 | |
| Domain | AAA+_ATPase | 1.27e-03 | 144 | 104 | 5 | IPR003593 | |
| Domain | AAA | 1.27e-03 | 144 | 104 | 5 | SM00382 | |
| Domain | - | 1.43e-03 | 148 | 104 | 5 | 2.60.40.150 | |
| Domain | SET | 2.14e-03 | 46 | 104 | 3 | SM00317 | |
| Domain | C2_dom | 2.24e-03 | 164 | 104 | 5 | IPR000008 | |
| Domain | SET_dom | 2.72e-03 | 50 | 104 | 3 | IPR001214 | |
| Domain | SET | 2.72e-03 | 50 | 104 | 3 | PS50280 | |
| Domain | BAR | 3.08e-03 | 15 | 104 | 2 | SM00721 | |
| Domain | BAR | 3.08e-03 | 15 | 104 | 2 | PF03114 | |
| Domain | BAR_dom | 3.50e-03 | 16 | 104 | 2 | IPR004148 | |
| Domain | - | 4.41e-03 | 119 | 104 | 4 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 4.41e-03 | 119 | 104 | 4 | IPR029058 | |
| Domain | BAR | 4.94e-03 | 19 | 104 | 2 | PS51021 | |
| Domain | RCC1 | 5.47e-03 | 20 | 104 | 2 | PF00415 | |
| Pubmed | 4.90e-08 | 234 | 107 | 9 | 36243803 | ||
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 9256245 | ||
| Pubmed | RPN1 POLR2C OLA1 EIF6 RCC2 DHX30 SF3B1 CCT5 AHNAK MACF1 SNX15 SNRNP200 | 1.93e-06 | 707 | 107 | 12 | 19738201 | |
| Pubmed | INTS1 EIF6 RCC2 DHX30 SF3B1 CCT5 AHNAK MACF1 ASCC3 SNRNP200 XPO7 | 5.71e-06 | 653 | 107 | 11 | 22586326 | |
| Pubmed | 5.72e-06 | 529 | 107 | 10 | 14621295 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24962568 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RELCH WASHC4 POLR2C CARS1 SCLY OLA1 EIF6 RCC2 GTF2E2 CCT5 AHNAK PANK4 MACF1 DNMBP SNRNP200 XPO7 | 9.69e-06 | 1455 | 107 | 16 | 22863883 |
| Pubmed | 1.01e-05 | 14 | 107 | 3 | 9373155 | ||
| Pubmed | A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. | 1.01e-05 | 14 | 107 | 3 | 9253601 | |
| Pubmed | ATP7A ANK2 RPN1 RCC2 PRUNE1 CCDC88A CCT5 AHNAK MACF1 ASCC3 SNRNP200 | 1.22e-05 | 708 | 107 | 11 | 39231216 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.31e-05 | 582 | 107 | 10 | 20467437 | |
| Pubmed | NET1 INTS7 POLR2C INTS1 OLA1 ECT2 EIF6 RCC2 C6orf132 DHX30 MEN1 GTF2E2 CCT5 MACF1 ASCC3 DNMBP | 1.38e-05 | 1497 | 107 | 16 | 31527615 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 1.68e-05 | 475 | 107 | 9 | 31040226 | |
| Pubmed | 1.86e-05 | 481 | 107 | 9 | 28190767 | ||
| Pubmed | 1.88e-05 | 177 | 107 | 6 | 26206133 | ||
| Pubmed | 2.79e-05 | 282 | 107 | 7 | 23667531 | ||
| Pubmed | PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome. | 2.81e-05 | 3 | 107 | 2 | 20440071 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 21373644 | ||
| Pubmed | Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia. | 2.81e-05 | 3 | 107 | 2 | 30315824 | |
| Pubmed | 3.38e-05 | 59 | 107 | 4 | 32382008 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | UBE3B INTS1 EIF6 C6orf132 DHX30 NCOR2 KMT2D PIK3C2B AHNAK PKN1 SNX15 DNMBP PRDM16 | 3.59e-05 | 1105 | 107 | 13 | 35748872 |
| Pubmed | 3.62e-05 | 60 | 107 | 4 | 19075228 | ||
| Pubmed | WASHC4 ANK2 ITSN1 POLR2C ZNF202 SYNC RILPL1 DHX30 FAIM SF3B1 HPS4 NAV3 MACF1 SNRNP200 | 4.07e-05 | 1285 | 107 | 14 | 35914814 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 26401052 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 20301515 | ||
| Pubmed | Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional Program. | 5.60e-05 | 4 | 107 | 2 | 26728228 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 23055499 | ||
| Pubmed | Mutations in dynein genes in patients affected by isolated non-syndromic asthenozoospermia. | 5.60e-05 | 4 | 107 | 2 | 18492703 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 25406310 | ||
| Pubmed | 6.20e-05 | 25 | 107 | 3 | 34004147 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | WASHC4 L3MBTL2 RPN1 POLR2C ECT2 EIF6 DHX30 NCOR2 SF3B1 CCT5 AHNAK MACF1 ASCC3 SNRNP200 | 7.07e-05 | 1353 | 107 | 14 | 29467282 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK16 NET1 ECT2 C6orf132 VPS13D FAM117A CCDC88A PIK3C2B AHNAK MACF1 DNMBP | 7.18e-05 | 861 | 107 | 11 | 36931259 |
| Pubmed | 7.19e-05 | 225 | 107 | 6 | 12168954 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | INTS1 OLA1 EIF6 RCC2 DHX30 SF3B1 CCT5 AHNAK MACF1 ASCC3 SNRNP200 XPO7 | 7.58e-05 | 1024 | 107 | 12 | 24711643 |
| Pubmed | BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites. | 7.83e-05 | 73 | 107 | 4 | 32347575 | |
| Pubmed | 8.27e-05 | 335 | 107 | 7 | 15741177 | ||
| Pubmed | 9.06e-05 | 340 | 107 | 7 | 29478914 | ||
| Pubmed | MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia. | 9.32e-05 | 5 | 107 | 2 | 28609655 | |
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 24334608 | ||
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 16940157 | ||
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 18026121 | ||
| Pubmed | Regulation of neuron survival through an intersectin-phosphoinositide 3'-kinase C2beta-AKT pathway. | 9.32e-05 | 5 | 107 | 2 | 17875942 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | INTS7 RPN1 POLR2C CARS1 OLA1 EIF6 RCC2 DHX30 GTF2E2 SF3B1 CCT5 AHNAK MACF1 SNRNP200 | 1.13e-04 | 1415 | 107 | 14 | 28515276 |
| Pubmed | 1.15e-04 | 245 | 107 | 6 | 21182205 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 1.18e-04 | 154 | 107 | 5 | 16055720 | |
| Pubmed | 1.25e-04 | 156 | 107 | 5 | 32850835 | ||
| Pubmed | 1.32e-04 | 32 | 107 | 3 | 20301301 | ||
| Pubmed | Assembly of the SMRT-histone deacetylase 3 repression complex requires the TCP-1 ring complex. | 1.40e-04 | 6 | 107 | 2 | 12502735 | |
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 21183682 | ||
| Pubmed | MLL associates specifically with a subset of transcriptionally active target genes. | 1.40e-04 | 6 | 107 | 2 | 16199523 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ANK2 L3MBTL2 EIF6 RCC2 DHX30 PRUNE1 GTF2E2 SF3B1 AHNAK MACF1 SNRNP200 | 1.47e-04 | 934 | 107 | 11 | 33916271 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | L3MBTL2 INTS7 RPN1 POLR2C INTS1 EIF6 RCC2 MEN1 NCOR2 KMT2D SF3B1 AHNAK SNRNP200 | 1.74e-04 | 1294 | 107 | 13 | 30804502 |
| Pubmed | ATP7A ANK2 L3MBTL2 RPN1 ITSN1 EIF6 DHX30 GTF2E2 CCDC88A SF3B1 PANK4 MACF1 ASCC3 SNRNP200 | 1.90e-04 | 1487 | 107 | 14 | 33957083 | |
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 1.92e-04 | 384 | 107 | 7 | 31059266 | |
| Pubmed | 1.92e-04 | 653 | 107 | 9 | 33742100 | ||
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 31178125 | ||
| Pubmed | 1.98e-04 | 271 | 107 | 6 | 26816005 | ||
| Pubmed | 2.02e-04 | 809 | 107 | 10 | 32129710 | ||
| Pubmed | 2.11e-04 | 390 | 107 | 7 | 17643375 | ||
| Pubmed | 2.23e-04 | 277 | 107 | 6 | 30745168 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 2.32e-04 | 670 | 107 | 9 | 22990118 | |
| Pubmed | 2.59e-04 | 8 | 107 | 2 | 17903303 | ||
| Pubmed | 2.66e-04 | 538 | 107 | 8 | 28524877 | ||
| Pubmed | 3.04e-04 | 549 | 107 | 8 | 38280479 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | L3MBTL2 ECT2 MEN1 NCOR2 KMT2D SF3B1 PANK4 PRDM15 SNRNP200 XPO7 | 3.20e-04 | 857 | 107 | 10 | 25609649 |
| Pubmed | 3.20e-04 | 418 | 107 | 7 | 34709266 | ||
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 24930734 | ||
| Pubmed | IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. | 3.33e-04 | 9 | 107 | 2 | 16127453 | |
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 9535835 | ||
| Pubmed | A revised nomenclature for mammalian acyl-CoA thioesterases/hydrolases. | 3.33e-04 | 9 | 107 | 2 | 16103133 | |
| Pubmed | 3.41e-04 | 300 | 107 | 6 | 28561026 | ||
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 3.81e-04 | 110 | 107 | 4 | 37219487 | |
| Pubmed | Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1. | 4.15e-04 | 10 | 107 | 2 | 24618850 | |
| Pubmed | 4.15e-04 | 10 | 107 | 2 | 22898778 | ||
| Pubmed | 4.15e-04 | 10 | 107 | 2 | 33074477 | ||
| Pubmed | 4.15e-04 | 10 | 107 | 2 | 10442092 | ||
| Pubmed | 4.15e-04 | 10 | 107 | 2 | 21768215 | ||
| Pubmed | 4.16e-04 | 47 | 107 | 3 | 8812413 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 4.23e-04 | 203 | 107 | 5 | 22083510 | |
| Pubmed | 4.83e-04 | 209 | 107 | 5 | 36779422 | ||
| Pubmed | 4.96e-04 | 591 | 107 | 8 | 15231748 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RPN1 POLR2C INTS1 ECT2 EIF6 RCC2 DHX30 SF3B1 CCT5 PANK4 ASCC3 SNRNP200 | 4.96e-04 | 1257 | 107 | 12 | 37317656 |
| Pubmed | Human CpG binding protein interacts with MLL1, MLL2 and hSet1 and regulates Hox gene expression. | 5.06e-04 | 11 | 107 | 2 | 18082152 | |
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | 5.24e-04 | 454 | 107 | 7 | 33226137 | |
| Pubmed | 5.38e-04 | 916 | 107 | 10 | 32203420 | ||
| Pubmed | 5.38e-04 | 327 | 107 | 6 | 31409639 | ||
| Pubmed | Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. | 5.61e-04 | 52 | 107 | 3 | 24591637 | |
| Pubmed | 5.64e-04 | 330 | 107 | 6 | 32529326 | ||
| Pubmed | 5.64e-04 | 330 | 107 | 6 | 21044950 | ||
| Pubmed | 5.71e-04 | 604 | 107 | 8 | 38803224 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 5.81e-04 | 462 | 107 | 7 | 31138677 | |
| Pubmed | 5.82e-04 | 332 | 107 | 6 | 37433992 | ||
| Pubmed | Activator-mediated recruitment of the MLL2 methyltransferase complex to the beta-globin locus. | 6.07e-04 | 12 | 107 | 2 | 17707229 | |
| Pubmed | Interplay of BAF and MLL4 promotes cell type-specific enhancer activation. | 6.07e-04 | 12 | 107 | 2 | 33712604 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 6.22e-04 | 221 | 107 | 5 | 29991511 | |
| Pubmed | 6.43e-04 | 615 | 107 | 8 | 31048545 | ||
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 6.61e-04 | 55 | 107 | 3 | 19468303 | |
| Pubmed | 6.77e-04 | 777 | 107 | 9 | 35844135 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 7.14e-04 | 130 | 107 | 4 | 35545047 | |
| Pubmed | 7.15e-04 | 13 | 107 | 2 | 16510874 | ||
| GeneFamily | Dyneins, axonemal | 3.64e-05 | 17 | 70 | 3 | 536 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 8.82e-05 | 4 | 70 | 2 | 1244 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.24e-04 | 66 | 70 | 4 | 722 | |
| GeneFamily | Acyl-CoA thioesterases | 6.52e-04 | 10 | 70 | 2 | 41 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 7.95e-04 | 11 | 70 | 2 | 1168 | |
| GeneFamily | Integrator complex | 1.50e-03 | 15 | 70 | 2 | 1366 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 1.94e-03 | 17 | 70 | 2 | 1197 | |
| GeneFamily | Carboxypeptidases | 2.96e-03 | 21 | 70 | 2 | 1321 | |
| GeneFamily | Nudix hydrolase family | 3.86e-03 | 24 | 70 | 2 | 667 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 4.18e-03 | 25 | 70 | 2 | 775 | |
| GeneFamily | CD molecules|C2-set domain containing|Sialic acid binding Ig like lectins | 5.23e-03 | 28 | 70 | 2 | 745 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 7.65e-03 | 34 | 70 | 2 | 487 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.53e-07 | 200 | 107 | 7 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | 5'-Adult-Appendix-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-06 | 164 | 107 | 6 | 29da0175bd3808a5b3039a6161c764105608ef96 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-06 | 164 | 107 | 6 | e83b632ac7e1dace946991ddfe1fbfbbffc3a88b | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-06 | 170 | 107 | 6 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-06 | 170 | 107 | 6 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-erythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-06 | 173 | 107 | 6 | a8fb8db6061fa4d8d56a7b45004ecbd344501573 | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic-erythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.57e-06 | 178 | 107 | 6 | 9c4950357087212b2388116ba8866c359628694d | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.89e-06 | 186 | 107 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.06e-06 | 192 | 107 | 6 | 8b4bbbadeac70f65378697120c754f10501b5651 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.49e-06 | 194 | 107 | 6 | b16ed97eb6b7b7a220e943474c0d85c141b6e3a5 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.49e-06 | 194 | 107 | 6 | 2210f0755882d8f04edb4c109fb17c3f9149f6f7 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-05 | 153 | 107 | 5 | 3b1b0cc8e9dd2b1484649789330713282ee44414 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-Tregs|GI_small-bowel / Manually curated celltypes from each tissue | 3.87e-05 | 157 | 107 | 5 | c44bd530e396b08f16f284e185dcb830843959ea | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-05 | 158 | 107 | 5 | c276a259e20ee704e2d04baf693e8d677f96f654 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.11e-05 | 159 | 107 | 5 | af137688e06a97ff97bb7def54f0dd164d155b11 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 4.63e-05 | 163 | 107 | 5 | 299ac2463b7f58eee419d822a2a2d64b973d87e9 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 164 | 107 | 5 | b81498c3934e0d52bf0329dc745e02966f9d8613 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.91e-05 | 165 | 107 | 5 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.91e-05 | 165 | 107 | 5 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 166 | 107 | 5 | a2ce44702a0cd5fa5872cac3302d3c451205feef | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 166 | 107 | 5 | 0f641302a6b71c4badaaf20f51162bfc2386b167 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-05 | 167 | 107 | 5 | 54576e9863403d0d5e3046e61db1ad695d88fee4 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-05 | 168 | 107 | 5 | ce5e92a1df3acfa5cd8d5a134e4af231dc592a13 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-05 | 168 | 107 | 5 | 22c89d4eb44573f6301069ec7ca7cbd0dd958403 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.50e-05 | 169 | 107 | 5 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-05 | 170 | 107 | 5 | 6210ee3bf29059e6149c047bb7e02c5f59441519 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_dendritic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.81e-05 | 171 | 107 | 5 | c2b7bbabc8f9afa8a1157b567d5f962d4b242919 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.81e-05 | 171 | 107 | 5 | e780e63510ca47036bc36ca40ecff4098596ee9e | |
| ToppCell | LV-17._Lymphocyte|World / Chamber and Cluster_Paper | 6.14e-05 | 173 | 107 | 5 | 212f013ff761cbab24a537071739867c08c402a4 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 173 | 107 | 5 | c63a615998d13b1725b5767f4ad2ec7e2b61db68 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.31e-05 | 174 | 107 | 5 | 53c2c132566a7682f3268c7f9138700f09c3b94d | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 174 | 107 | 5 | 9d5dcd46cf346c381dea68ada6665f7fb68114a3 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 174 | 107 | 5 | 53cec5c666c45278a71c21dd9c62a052a97e0fdf | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 174 | 107 | 5 | 81ab196e36cac2a7974d6e3fe457efffddfd03bb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-05 | 176 | 107 | 5 | 8488997e0f02e874f53fae1690da63e0dd1d0780 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-05 | 176 | 107 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-05 | 178 | 107 | 5 | b4e15c176875cd226854a0019495309d02730c42 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-05 | 178 | 107 | 5 | 0b456ac768e026c3ecd5a9a4f43d6f126e7685a1 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 7.22e-05 | 179 | 107 | 5 | 99894067e2c2a3ed53abdc5434410c3172693496 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-05 | 179 | 107 | 5 | 7e6da098976c7801d31dcc0201f813d2bc8b07fc | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 180 | 107 | 5 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.41e-05 | 180 | 107 | 5 | cc31d2cd06161300b91b17a67bb432b75f0d719b | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 180 | 107 | 5 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 180 | 107 | 5 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | LV-17._Lymphocyte|LV / Chamber and Cluster_Paper | 7.61e-05 | 181 | 107 | 5 | 81fafa69c8c240250a667a5f3b321e8be1b9a288 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-05 | 181 | 107 | 5 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.01e-05 | 183 | 107 | 5 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-05 | 184 | 107 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.22e-05 | 184 | 107 | 5 | e0beb016823514eebdbfc13beb0807efb4470f08 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-05 | 184 | 107 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-05 | 184 | 107 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.22e-05 | 184 | 107 | 5 | 22c18964818fc9c8f18051f836d718937b0d8d12 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-05 | 186 | 107 | 5 | ac6e32cf07f0f013101ca7aedae0c562857f182b | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-05 | 186 | 107 | 5 | 7cdcf507a9a1349ed2cf62b79116367c3fc732dd | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.87e-05 | 187 | 107 | 5 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.87e-05 | 187 | 107 | 5 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.87e-05 | 187 | 107 | 5 | 401be371b32066db926de3415bb4ce9465749dc3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.87e-05 | 187 | 107 | 5 | 93c78fc7f126132eb84feb47be2c4e8c568b9e91 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.09e-05 | 188 | 107 | 5 | e82104f71bcdab7392fdb076dc3560255964fd9e | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.56e-05 | 190 | 107 | 5 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.56e-05 | 190 | 107 | 5 | b56c55f608b30f7379941ac7d5f0f5200f305fca | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.56e-05 | 190 | 107 | 5 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 9.80e-05 | 191 | 107 | 5 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.80e-05 | 191 | 107 | 5 | 2699e9bb872f2b561bb976dfdc2746e359bc9daf | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.80e-05 | 191 | 107 | 5 | d78d4fbb0b8317dbf14e32182466a432abef3e93 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.80e-05 | 191 | 107 | 5 | 4b94c8b0183ae07d173646b7e7e1d9db04ec9637 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.00e-04 | 192 | 107 | 5 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.00e-04 | 192 | 107 | 5 | dfb9101622f7d2f2c392e850cff07becfc8c655e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.00e-04 | 192 | 107 | 5 | d39133cf1a20af6f2970188630fc3b27a4cfc9c5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 193 | 107 | 5 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 1.03e-04 | 193 | 107 | 5 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 193 | 107 | 5 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-04 | 194 | 107 | 5 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 1.08e-04 | 195 | 107 | 5 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease, Lineage and Cell Type | 1.08e-04 | 195 | 107 | 5 | 35b2fe0588877d30cbd5d3ae259fcfd959907429 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 195 | 107 | 5 | 247803cf58c6d9c561a52aa34e581188ddad197e | |
| ToppCell | Control-B_memory-3|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.13e-04 | 197 | 107 | 5 | b86385c6c1d52ef4e3d855004d77afab61556978 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 197 | 107 | 5 | 0523aec9713ae21e6b879aa98e07fa2576610d5f | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-04 | 197 | 107 | 5 | 363ae03310f63a586ba3cea2a59f35d5a335a54e | |
| ToppCell | Healthy/Control-cDC|World / Disease group and Cell class | 1.13e-04 | 197 | 107 | 5 | 4497d4073f4d3e74de907325fba9eb4af5766bf4 | |
| ToppCell | Healthy/Control-cDC|Healthy/Control / Disease group and Cell class | 1.13e-04 | 197 | 107 | 5 | 926423aae9fcf654f84b0f7621103a6a22d3aced | |
| ToppCell | Healthy_donor-cDC|World / disease group, cell group and cell class (v2) | 1.13e-04 | 197 | 107 | 5 | a545fe3a80cd721bf01115bbb645753840ec9f40 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.13e-04 | 197 | 107 | 5 | 5bcf963f21d23edafef1e90dc1de24cd3b0fccce | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.13e-04 | 197 | 107 | 5 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.13e-04 | 197 | 107 | 5 | bd7e18a0fed085cfb8ed0e478d1f172a173febbe | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.13e-04 | 197 | 107 | 5 | 7e06aee2add54eeff4a9927d9b04b5797160113b | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 104 | 107 | 4 | fdf4599de8cd4ccf1bd7ede4e7af63d69c108b43 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 104 | 107 | 4 | a3d061170fe49d023ac31dbaeb2b5d2347988078 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 198 | 107 | 5 | 6a4161680b46b2c12353a693c403b5a4bb3da03f | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 198 | 107 | 5 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells-Mast-cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.19e-04 | 199 | 107 | 5 | 892ca0dc9928d3985bf99de8afc68c06d22e6e2e | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-04 | 199 | 107 | 5 | 368e2bafae00ce8e9c6ea480f81b78f96b680acd | |
| ToppCell | mild-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.22e-04 | 200 | 107 | 5 | 86f585bf9066b179bbcbc703bf43f15da4a07284 | |
| ToppCell | COVID-19-COVID-19_Severe-Others-RBC|COVID-19_Severe / Disease, condition lineage and cell class | 1.22e-04 | 200 | 107 | 5 | 308f74e7e13ecc6d133c219c42cc8895a96644c8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-04 | 200 | 107 | 5 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.22e-04 | 200 | 107 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 200 | 107 | 5 | f7c3a8f5ac156c05ad7335d6d142c154c7d86449 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-04 | 200 | 107 | 5 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | mild-cDC|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.22e-04 | 200 | 107 | 5 | d6409ee5b9067be3dd2f852825e09151b5b22d7c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.22e-04 | 200 | 107 | 5 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| Disease | Usher syndrome, type 2C | 1.25e-05 | 2 | 105 | 2 | C2931213 | |
| Disease | Usher syndrome type 2C | 1.25e-05 | 2 | 105 | 2 | cv:C2931213 | |
| Disease | Usher syndrome type 2C (is_implicated_in) | 1.25e-05 | 2 | 105 | 2 | DOID:0110839 (is_implicated_in) | |
| Disease | USHER SYNDROME, TYPE IIC | 1.25e-05 | 2 | 105 | 2 | 605472 | |
| Disease | Malignant neoplasm of breast | TRERF1 ANK2 NET1 ABHD12B RCCD1 OLA1 NUDT17 ECT2 EIF6 KMT2D CCT5 MACF1 CLUL1 SMOX | 2.77e-05 | 1074 | 105 | 14 | C0006142 |
| Disease | X-16935 measurement | 2.60e-04 | 7 | 105 | 2 | EFO_0800763 | |
| Disease | calpastatin measurement | 3.46e-04 | 8 | 105 | 2 | EFO_0008065 | |
| Disease | X-24747 measurement | 3.46e-04 | 8 | 105 | 2 | EFO_0022135 | |
| Disease | X-17653 measurement | 4.44e-04 | 9 | 105 | 2 | EFO_0800783 | |
| Disease | morbid obesity (is_marker_for) | 5.54e-04 | 10 | 105 | 2 | DOID:11981 (is_marker_for) | |
| Disease | alpha wave measurement, electroencephalogram measurement | 5.54e-04 | 10 | 105 | 2 | EFO_0004357, EFO_0006870 | |
| Disease | X-11308 measurement | 6.76e-04 | 11 | 105 | 2 | EFO_0800693 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 6.76e-04 | 11 | 105 | 2 | EFO_0021862 | |
| Disease | Colorectal Carcinoma | 9.16e-04 | 702 | 105 | 9 | C0009402 | |
| Disease | X-24588 measurement | 9.54e-04 | 13 | 105 | 2 | EFO_0800898 | |
| Disease | male infertility (implicated_via_orthology) | 9.54e-04 | 13 | 105 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | undecenoylcarnitine (C11:1) measurement | 9.54e-04 | 13 | 105 | 2 | EFO_0800588 | |
| Disease | X-17654 measurement | 1.28e-03 | 15 | 105 | 2 | EFO_0800784 | |
| Disease | response to methotrexate, neurotoxicity | 2.06e-03 | 19 | 105 | 2 | EFO_0011057, GO_0031427 | |
| Disease | Mammary Carcinoma, Human | 2.76e-03 | 525 | 105 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.76e-03 | 525 | 105 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 2.82e-03 | 527 | 105 | 7 | C1458155 | |
| Disease | mosaic loss of chromosome Y measurement | 2.95e-03 | 80 | 105 | 3 | EFO_0007783 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 3.02e-03 | 23 | 105 | 2 | C1708353 | |
| Disease | Breast Carcinoma | 3.16e-03 | 538 | 105 | 7 | C0678222 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| THLPAGIFRDLEELV | 326 | P22792 | |
| EEELLRILDIPDGHR | 231 | Q9C073 | |
| LLILHGEDDRTVPLE | 296 | Q7Z5M8 | |
| HLQELGREIALPIEA | 281 | Q9Y3L3 | |
| TLLARLDGIPELDEH | 841 | Q8WXG9 | |
| ADRHLLELPLEGLSV | 2331 | Q8IYW2 | |
| RTPLAVELEVLDGHD | 161 | P49753 | |
| LEVLDGHDTEPGRLL | 106 | Q3I5F7 | |
| DLELSLPAIHVEGLD | 5121 | Q09666 | |
| ELDNLPLHRGDLVIL | 81 | Q6XZF7 | |
| PEREALVVLHEDVRL | 86 | Q96CM8 | |
| DGEDIILRVPIHDIA | 126 | Q9BSQ5 | |
| PLAVLLLTDGDVHIR | 1096 | Q7L2E3 | |
| EELILRIPTHEIAAA | 126 | Q9NUG4 | |
| ADRLLALVIHPEEDV | 291 | Q5T9G4 | |
| EIIGPRDIIHTIESL | 611 | Q04656 | |
| QIELRILTHLSGDPE | 626 | Q7Z5Q5 | |
| EAPRLIEGLSHEVIV | 191 | Q9P258 | |
| GHGTLEAELEPRLLE | 191 | A6NED2 | |
| RHLLEAAIPERVEEI | 156 | O95072 | |
| IEEKLHEEIDRVIGP | 321 | P05181 | |
| LPLGDERCTHLVVEE | 301 | Q9H8V3 | |
| LLISHAIEALILDPE | 711 | Q9NVH2 | |
| EGSVDPIRDIEIIHE | 136 | Q9NTK5 | |
| RVLGAHRDIILESIP | 786 | Q12851 | |
| ELGREEPDLVLLSLV | 26 | O00255 | |
| IPLHEDLLTRIGEAT | 226 | Q7Z628 | |
| HDQVVELLLERGAPL | 311 | Q01484 | |
| LELHTELLESGRELP | 111 | Q9P260 | |
| ALEEAVAEVLDHRPI | 116 | Q86TP1 | |
| LEELDKSHLEGELRP | 2071 | Q9Y618 | |
| RSLLDHPVLEELDLS | 301 | Q5JU00 | |
| QGLIEVRSPHLEELL | 1546 | Q8N201 | |
| GLVEEGELIEVVHLP | 171 | O95848 | |
| VELEEDGRARPLVLH | 246 | P0C025 | |
| EVEVISRHLPALGLR | 6 | Q96L50 | |
| PGEIIAVRVKEEHLD | 666 | Q969R5 | |
| GLEVHLKETLPRDEA | 581 | Q9NQG7 | |
| EESGDLHLPHEELLL | 96 | Q9BQE6 | |
| LHLPHEELLLLTDGE | 101 | Q9BQE6 | |
| IIELSEERDGLHFLP | 211 | Q3V6T2 | |
| EHPLELIRVEVEILD | 111 | Q9Y5F6 | |
| HEGGIEDLVRPLLAI | 586 | Q9H5P4 | |
| IGDLIRSHNLEVPEL | 1986 | Q8IVL0 | |
| HLEDSLSLGRPLLIE | 3501 | Q96JB1 | |
| LSLGRPLLIEDIHEE | 3506 | Q96JB1 | |
| PESEILSLHLLVEEL | 756 | O94854 | |
| TEELLRHVAPGLHLE | 346 | Q92985 | |
| EEIPKEDGILVLSRH | 36 | Q13087 | |
| EQLPGKLLEHRILEE | 196 | O00750 | |
| DPVVHSALQEERLLL | 676 | Q9NVE7 | |
| LVHPDLDRETEEILA | 116 | P56537 | |
| DELLRHPVTGEVVER | 821 | Q5T0Z8 | |
| LESVGLHEPLVEELR | 716 | Q9P2D7 | |
| EEGLLLDVTLVIEDH | 26 | Q96M94 | |
| VALKEIRLEHEEGAP | 191 | Q00536 | |
| EGLPEEVLALIFRHL | 6 | Q96CD0 | |
| LHEVPTGEIVVRLDL | 1701 | Q15811 | |
| EPGHTELLRELLASL | 56 | Q13158 | |
| EGIIHTLIVDNREIP | 161 | Q9NVQ4 | |
| RELLVIELSDNPGVH | 86 | P16870 | |
| LGAEHVITEEELRRP | 231 | Q9BV79 | |
| ILDLVGVLHDPETLL | 231 | P08397 | |
| TVRLLDGEEIHPLSV | 1346 | Q6ZTR5 | |
| LLVVDHIERQEDSPI | 581 | Q8IZU8 | |
| HLEDSLSLGRPLLIE | 3636 | Q8TE73 | |
| TLPEDVGRVLLLRVH | 56 | O15296 | |
| LLRPAVGEIFVDELH | 266 | Q9Y2I2 | |
| RGDTHPLTLDEILDE | 91 | P29084 | |
| IDLLPDGRHAVVEVE | 131 | Q5H9L4 | |
| LIHELVLLREPALQE | 196 | Q9H7C4 | |
| VIVPDDDRSLINLHL | 256 | Q9NWD8 | |
| ILPELGVRFEDHEGL | 621 | P49589 | |
| GDAVDLERLPVHLLA | 141 | Q8N103 | |
| VLAVRIDDLDHLPET | 1251 | P57071 | |
| VIKDIEPGEELLVHV | 196 | Q9HAZ2 | |
| HLEEDRHLGILGPVI | 446 | Q9BQS7 | |
| LALEPELEARLAHLG | 71 | P04843 | |
| GLLELPRVHVRDEGE | 311 | Q9NYZ4 | |
| LGDIILLTDVVIHED | 501 | Q86V20 | |
| LTHLPEEIGTLENLE | 506 | Q9UQ13 | |
| LLEEAEQLLDRGIHP | 116 | P48643 | |
| PDLGAVELRIEELRH | 206 | Q16512 | |
| HRLGLIPLISDDIVD | 66 | P19387 | |
| DEVHLLHEDRGPVLE | 611 | Q8N3C0 | |
| IIDEIHLLGEERGPV | 1451 | Q8N3C0 | |
| HLLGEERGPVLEVIV | 1456 | Q8N3C0 | |
| ELELGLHRVRELPEL | 146 | Q96RK1 | |
| VPALHTELDEAIRLV | 336 | Q15846 | |
| ELEDVLLLLERFLPH | 286 | Q9Y2C2 | |
| EPEEAELILHDALRL | 111 | Q6DKK2 | |
| DSIRLPLEHLVEEQV | 146 | Q96I15 | |
| IAEIIERGIRQHPEL | 211 | Q8N4P2 | |
| LHLLEEGQGIPREEL | 2466 | Q8N2C7 | |
| ELVSRDPGHFLILLE | 46 | Q8WYR1 | |
| HHVAPELDELRLELD | 71 | Q5EBL4 | |
| PHLRSLVEIIEHGLV | 681 | O75533 | |
| GEVTRPLEVSRDLHI | 126 | Q9NRS6 | |
| RVVELLAEGIPAHVI | 241 | Q9NWM0 | |
| SEVDPHLEELLGLVV | 331 | Q6ZS81 | |
| AEEELPHLLTERLTD | 121 | Q5BVD1 | |
| LLRVEIHNPLLEEEG | 671 | Q9BZZ2 | |
| EIHLLHDDRGPVLEA | 616 | O75643 | |
| LLHLGSLSPRVLEEE | 316 | Q7Z3V4 | |
| IAEIIERGIRQHPEL | 211 | Q86WT1 | |
| EHLGELLTVLLTLDE | 191 | Q2M389 | |
| VHIILRDGLEDPLED | 421 | Q9UIA9 | |
| EVLLHPLVAETRLGE | 581 | Q86VR7 | |
| PDLHDIERALVGKDL | 1381 | P01266 | |
| EDLSLEDIHRPVLGE | 331 | O95125 | |
| RVLGDHLLLDPTHEL | 691 | Q96PN7 | |
| IREGTRHTLDPVLEL | 2626 | Q5THJ4 | |
| VASELPLLIEDLLEH | 3241 | O14686 | |
| PEEVESVHRILAAIL | 266 | B0I1T2 | |
| LVERPHRGILAVLDE | 456 | B0I1T2 |